stars 1 stars 2 stars 3

Backed by Boomerang Ventures, PrecisionCare AI is redefining musculoskeletal therapy through our patented Quantitative Soft Tissue Manipulation (QSTM®) technology — the first and only solution delivering objective, data-driven treatments with real-time quantification. Supported by an issued patent for the "Quantification of Force During Soft Tissue Massage," our platform introduces a new standard of care with measurable data, eliminating subjectivity, improving outcomes, and promoting compliance. Through our AI-Powered SaaS Cloud Platform with precision therapeutic medical devices, PrecisionCare offers a next generation in soft tissue manipulation exceeding any existing capabilities. We are building the future of MSK care to transform Rehabilitation & Physical Therapy, Sports Medicine & Athletic Trainers, Chiropractic Practices, and Massage Therapy with QSTM® solutions offering precise, data-driven devices.

Website https://qstm.co
Employees 4 (2 on RocketReach)
Industry Medical Equipment Manufacturing

PrecisionCare AI Questions

Jennifer Holmes is the CEO of PrecisionCare AI.

2 people are employed at PrecisionCare AI.

Top PrecisionCare AI Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users